journal article·2025-11Open access

A Herbal‐Piezoelectric Heterojunction Strategy to Potentiate Bacterial Cuproptosis‐Like Death and Remodel the Inflammatory Microenvironment in Infection‐Associated Implant Osteomyelitis

Guannan Zhang, Zehao Li, Ying Lu, Jianbo Song, Xingyu Liang, Peide Han, Xiaohong Yao, Yongqiang Yang, Xiangyu Zhang

Advanced Science· Volume 12· Issue 43

Abstract

Abstract For infection‐associated implant osteomyelitis (IAOM) caused by Staphylococcus aureus , copper‐induced bacterial death holds great potential. However, inducing bacterial cuproptosis‐like death using low concentrations of copper (Cu) ions remains a challenge. Therefore, a “herbal‐piezoelectric heterojunction” (Herbal‐Piezo‐HJ) is designed by integrating berberine (Ber) with Cu ion‐doped Strontium titanate (SrTiO 3 , STO) on a Ti substrate (STO‐Cu@Ber). Ber and acoustoelectric therapy (SPT) synergistically enhance the efficacy of low‐concentration Cu ions in inducing bacterial cuproptosis‐like death. The formation of inorganic/organic heterojunctions significantly enhances piezoelectric performance, generating marked electronic asymmetry at the interface under ultrasonic (US) irradiation and producing a large amount of reactive oxygen species (ROS). ROS and Ber together damage bacterial cell walls and membranes, promoting Cu ion uptake into bacterial cells. Consequently, the bacterial glycolytic respiratory mode is altered, the tricarboxylic acid cycle is significantly inhibited, and a large amount of nutrients are leaked, resulting in bacterial cuproptosis‐like death. Additionally, Herbal‐Piezo‐HJ downregulates arachidonic acid metabolites, activates the cyclic adenosine monophosphate (cAMP) signaling pathway to resolve the inflammatory response after infection clearance, and promotes bone integration. Overall, the combination of herbal therapy and SPT to enhance bacterial cuproptosis‐like death offers a promising strategy for eradicating IAOM.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopedic Infections and Treatments · Nanoplatforms for cancer theranostics · Osteomyelitis and Bone Disorders Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University Tongji Shanxi Hospital Taiyuan 030032 China

Shanxi Provincial Key Laboratory for Translational Nuclear Medicine and Precision Protection Taiyuan 030006 China

Shanxi Key Laboratory of Biomedical Metal Materials College of Materials Science and Engineering Taiyuan University of Technology Taiyuan 030024 China

The First Hospital of Shanxi Medical University Taiyuan 030001 China

College of Materials Science and Engineering Taiyuan University of Technology Taiyuan 030024 China

College of Biomedical Engineering Taiyuan University of Technology Taiyuan 030024 China

National Graphene Products Quality Inspection and Testing Center (Jiangsu) Special Equipment Safety Supervision Inspection Institute of Jiangsu Province Wuxi 214174 China

Funding

National Natural Science Foundation of China

References (59)

Show source-provided references
1. 10.1016/j.actbio.2020.09.04110.1016/j.actbio.2020.09.041 ↗
2. 10.1016/j.biomaterials.2022.12166310.1016/j.biomaterials.2022.121663 ↗
3. 10.1002/advs.20210068110.1002/advs.202100681 ↗
4. 10.1016/j.jinf.2012.09.00610.1016/j.jinf.2012.09.006 ↗
5. 10.1016/j.biomaterials.2015.12.01210.1016/j.biomaterials.2015.12.012 ↗
6. 10.1002/advs.20230885010.1002/advs.202308850 ↗
7. 10.1016/j.mtbio.2022.10044710.1016/j.mtbio.2022.100447 ↗
8. 10.1126/science.abf052910.1126/science.abf0529 ↗
9. 10.1016/j.cej.2022.13721410.1016/j.cej.2022.137214 ↗
10. 10.1002/adfm.20230819710.1002/adfm.202308197 ↗
11. 10.1002/adma.20230343210.1002/adma.202303432 ↗
12. 10.1002/adma.20240595310.1002/adma.202405953 ↗
13. 10.1038/s41467-024-45619-y10.1038/s41467-024-45619-y ↗
14. 10.1016/j.mattod.2023.06.02410.1016/j.mattod.2023.06.024 ↗
15. 10.1016/j.jhazmat.2024.13468010.1016/j.jhazmat.2024.134680 ↗
16. 10.1002/advs.20240338810.1002/advs.202403388 ↗
17. 10.1002/adma.20240497110.1002/adma.202404971 ↗
18. 10.1002/med.2196310.1002/med.21963 ↗
19. 10.1002/advs.20210074910.1002/advs.202100749 ↗
20. 10.1002/adma.20230872610.1002/adma.202308726 ↗
21. 10.1016/j.biomaterials.2024.12252810.1016/j.biomaterials.2024.122528 ↗
22. 10.1021/acsnano.4c0095210.1021/acsnano.4c00952 ↗
23. 10.1002/adma.20240619210.1002/adma.202406192 ↗
24. 10.1016/j.mtcomm.2024.10982610.1016/j.mtcomm.2024.109826 ↗
25. 10.1021/acs.nanolett.4c0165610.1021/acs.nanolett.4c01656 ↗
26. 10.1016/j.nantod.2024.10245310.1016/j.nantod.2024.102453 ↗
27. 10.1002/adfm.20241421110.1002/adfm.202414211 ↗
28. 10.1002/adfm.20231355310.1002/adfm.202313553 ↗
29. Zhang Y. · Adv. Funct. Mater. · 2021 · 50
30. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
31. Du Y. · Adv. Mater. · 2024 · 36
32. 10.1016/j.cej.2021.13115510.1016/j.cej.2021.131155 ↗
33. 10.1016/j.ccr.2021.21388810.1016/j.ccr.2021.213888 ↗
34. 10.1021/acsnano.2c1020310.1021/acsnano.2c10203 ↗
35. 10.1002/adfm.20230416210.1002/adfm.202304162 ↗
36. 10.1021/acsnano.1c0840910.1021/acsnano.1c08409 ↗
37. 10.1016/j.jconrel.2018.07.01410.1016/j.jconrel.2018.07.014 ↗
38. 10.1002/advs.20241199710.1002/advs.202411997 ↗
39. 10.1016/j.biomaterials.2020.12063410.1016/j.biomaterials.2020.120634 ↗
40. 10.1002/adfm.20240542110.1002/adfm.202405421 ↗
41. 10.1021/jacs.4c0510310.1021/jacs.4c05103 ↗
42. 10.1016/j.annonc.2022.07.04110.1016/j.annonc.2022.07.041 ↗
43. 10.1002/adhm.20180067510.1002/adhm.201800675 ↗
44. 10.1126/science.aam792810.1126/science.aam7928 ↗
45. 10.1016/j.jare.2018.03.00510.1016/j.jare.2018.03.005 ↗
46. 10.1016/j.cell.2020.08.04110.1016/j.cell.2020.08.041 ↗
47. 10.1007/s10753-021-01439-610.1007/s10753-021-01439-6 ↗
48. 10.1016/j.phrs.2020.10503010.1016/j.phrs.2020.105030 ↗
49. 10.3390/molecules2421387510.3390/molecules24213875 ↗
50. 10.1016/j.matdes.2023.11231310.1016/j.matdes.2023.112313 ↗
51. 10.3390/kinasesphosphatases203001510.3390/kinasesphosphatases2030015 ↗
52. 10.1186/s12964-020-00564-310.1186/s12964-020-00564-3 ↗
53. 10.1016/j.colsurfb.2024.11389110.1016/j.colsurfb.2024.113891 ↗
54. 10.1016/j.actbio.2012.01.02110.1016/j.actbio.2012.01.021 ↗
55. 10.1016/j.bioactmat.2024.01.00310.1016/j.bioactmat.2024.01.003 ↗
56. 10.1016/j.actbio.2020.10.03010.1016/j.actbio.2020.10.030 ↗
57. 10.1016/j.compositesb.2022.10975910.1016/j.compositesb.2022.109759 ↗
58. 10.1016/j.actbio.2024.03.02010.1016/j.actbio.2024.03.020 ↗
59. 10.1016/j.jcis.2025.01.09410.1016/j.jcis.2025.01.094 ↗